On July 25, 2022, the U.S. Securities and Exchange Commission (“SEC”) announced insider trading charges against ten individual defendants across four separate cases (Bhardwaj,.
On July 29, the Delaware Court of Chancery issued a noteworthy decision confirming the broad application of the "MFW" framework based on the Delaware Supreme Court's decision in Kahn v..
On June 3, 2022, the Delaware Court of Chancery dismissed the final two counts in an action against California biotech firm Vaxart, Inc., finding that plaintiffs failed to adequately.
A claim under a business-to-business contract was dismissed this week when Delaware’s Chancery Court held that, under an earlier agreement between the parties, the dispute had to be.
A Delaware vice chancellor on Monday shot down as unsupported a stockholder bid for an order fast-tracking action on a preliminary injunction to block an Arena Pharmaceuticals Inc. shareholder vote on a $6.7 billion company acquisition by Pfizer Inc.